Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Black lines indicate locations of bait used in this study.Zebrafish Udu-binding proteins isolated by yeast two-hybrid analysis.CategoryBaitPBS*Prey binding regionSymbolName (accession number)GO termsLipid metabolism-related1Dunknown-3786Apobb.1Apolipoprotein Bb, tandem duplicate 1 (apobb.1), mRNA (NM_001030062.1 )Lipid transporter activity1D− 1 ~ 399Ephx2Epoxide hydrolase 2, cytoplasmic, transcript variant X1, mRNA (XM_021467153.1)Epoxide hydrolase activityTranscriptional regulation1D432 ~ 1,248Pax7bPaired box 7b (NM_001146149.1)Sequence-specific DNA binding2D92 ~ 652Hoxc4aHomeobox C4a, mRNA (NM_131122.2)Sequence-specific DNA binding1D96 ~ 600Otx1Orthodenticle homeobox 1, mRNA (NM_131250.2)Sequence-specific DNA binding1D− 1 ~ 954Cry3aCryptochrome circadian regulator 3a, transcript variant 1, mRNA (NM_001313822.1)Negative regulation of transcription; sequence-specific DNA binding2D− 7 ~ 754Pelp1Proline, glutamate and leucine rich protein 1, mRNA (XM_001338982.7)Transcription factor binding; chromatin bindingRNA-binding/processing1D2094 ~ 2,781Heatr6HEAT repeat containing 6 (NM_001114313.1)RNA binding2D− 1 ~ 614Fbrsl1Fibrosin-like 1 protein variant 1a mRNA, complete cds, alternatively spliced (KY492379.1)RNA binding2D− 1 ~ 1,026Rbmx2RNA binding motif protein X-linked 2, mRNA (NM_001025166.1)RNA bindingApoptosis/Cell proliferation/DNA replication2D1,155 ~ 1893Mcm3Minichromosome maintenance complex component 3, mRNA (NM_212567.2)DNA replication origin binding; helicase activity2D1971 ~ 2,229Mcm4minichromosome maintenance complex component 4, mRNA (NM_198913.2)DNA replication origin binding; helicase activity1D− 1 ~ 1,355BniplBCL2/adenovirus E1B 19kD interacting protein, like, transcript variant X1, mRNA (XM_009292526.3)Exopolyphosphatase activity2D270 ~ 1744Gulp1bGULP, engulfment adaptor PTB domain containing 1b, transcript variant X5, mRNA (XM_001345116.6)Apoptotic process2D135 ~ 706Gpatch11G patch domain containing 11, mRNA; zgc92714 (NM_001002393.1)Nucleic acid bindingSignaling pathways1D1,356 ~ unknownDlcdeltaC, mRNA (NM_130944.1)PDZ domain binding; Notch binding1DUnknown ~ 1,216NapbaN-ethylmaleimide-sensitive factor attachment protein, beta, mRNA (NM_001020655.2)Soluble NSF attachment protein activity; syntaxin binding2D2,640 ~ 3,309Dock6Danio rerio dedicator of cytokinesis 6, transcript variant X1, misc_RNA (XR_660514.3)Guanyl-nucleotide exchange factor activityProtein translocation/ processing1DUnknown ~ 915Ssr1Signal sequence receptor, alpha, mRNA (NM_201327.1)Cellular response to estrogen1D− 1 ~ 559Naa15bN(alpha)-acetyltransferase 15, NatA auxiliary subunit b, mRNA (NM_203321.2)Peptide alpha-N-acetyltransferase activityCytoskeleton1D− 1 ~ 628AgrnAgrin, mRNA (NM_001177452.1)Serine-type endopeptidase inhibitor activity1D− 1 ~ 608Plecaplectin a, mRNA (NM_001100032.1)Ankyrin binding; actin binding1D147 ~ 841Actc1cardiac muscle alpha actin 1 (NM_001002066.1)Nucleotide binding; ATP binding2D− 1 ~ unknownNebNebulin (neb), transcript variant X41, mRNA (XM_021474182.1)Actin filament binding2D− 1 ~ unknownCnn3bCalponin 3, acidic b, mRNA (NM_001024073.1)Actin binding; calmodulin bindingOthers1D225 ~ 661Slc25a3bSolute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3b, mRNA (NM_213722.1)Inorganic phosphate transmembrane transporter activity*PBS is a score that is automatically computed through algorithms; D means “moderate confidence in the interaction”.Mouse GON4L-binding proteins isolated by yeast two-hybrid analysis.CategoryBaitPrey binding regionPrey librarySymbolName (accession number)GO termsLipid metabolism-related316 ~ 240Mouse embryoGCGroup specific component (NM_008096)Vitamin D-binding; vitamin transmembrane transporter activity3− 3 ~ 374− 13 ~ 973 ~ 374Mouse B cell/Cardiac cellLIASLipoic acid synthetase, mitochondrial protein (NM_024471)Lipoate synthase activity; transferase activityTranscriptional regulation35 ~ 176Mouse embryoFOXA2Forkhead box a2 (NM_010446)DNA-binding transcription factor activity3189 ~ 547Mouse B cellHIVEP1Human Immunodeficiency Virus Type I Enhancer Binding Protein 1 (NM_007772)DNA-binding transcription factor activity3259 ~ 580Mouse B cellARNTL2Aryl hydrocarbon receptor nuclear translocator-like 2, also known as Bmal2 (NM_172309)DNA-binding transcription factor activity3821 ~ 1,006Mouse B cellBRD4Bromodomain containing 4 (NM_020508)Lysine-acetylated histone binding; chromatin binding41,233 ~ 1,4211,355 ~ 1,421Mouse Cardiac cellNPATNuclear Protein, Ataxia-Telangiectasia Locus (NM_001081152)Regulation of transcription involved in G1/S transition of mitotic cell cycle; transcription coactivator activity of histones3654 ~ 897Mouse B cellCRAMP1LCramped-like, cramp1L (NM_020608)DNA binding; nucleus; chromatin binding3591 ~ 726Mouse Cardiac cellSKIski sarcoma viral oncogene homolog (NM_011385)SMAD binding; transcription corepressor activity3118 ~ 296Mouse B cellTLE3Transducin-Like Enhancer Of Split 3, Homolog Of Drosophila E (NM_009389)Transcription corepressor activityRNA-binding/processing3338 ~ 532Mouse embryoTHOC1Tho complex 1, also known as Tho1, HPR1 (NM_153552)DNA binding; RNA binding; protein binding; nucleus; cytoplasm; mRNA export from nucleus; RNA splicing; replication fork processing3− 6 ~ 126− 3 ~ 1268 ~ 9724 ~ 118Mouse Cardiac cell/Mouse embryoRPS25Ribosomal Protein S25 (NM_024266)Structural constituent of ribosome3401 ~ 655431 ~ 664435 ~ 711Mouse B cellDDX10DEAD-Box Helicase 10 (XM_284494)RNA binding; RNA helicase activity; ATP binding374 ~ 458200 ~ 47726 ~ 479373 ~ 511Mouse B cell/ Mouse embryoCTNNBL1Beta-catenin-like protein 1 (NM_025680)mRNA splicing via spliceosome; protein binding; positive regulation of apoptotic processApoptosis/Cell proliferation/DNA replication3625 ~ 729545 ~ 646Mouse B cell/ Mouse embryoBAP1BRCA1-associated protein 1 (NM_027088)Chromatin binding; thiol-dependent ubiquitinyl hydrolase activity3− 21 ~ 202Mouse embryoCACYBPCalcyclin binding protein (NM_009786)Tubulin binding; ubiquitin protein ligase binding; S100 protein binding3423 ~ 715Mouse Cardiac cellCITCitron Rho-interacting Kinase (NM_007708)Protein serine/threonine kinase activity; mitotic cytokinesis3554 ~ 831574 ~ 704Mouse B cell/Cardiac cellDNMT1DNA methyltransferase 1 (AF162282)Chromatin binding; DNA (cytosine-5-)-methyltransferase activity3254 ~ 656547 ~ 643Mouse B cell/Cardiac cellKIF20Arabkinesin-6 (Y09632)ATPase activity; microtubule motor activity; nucleotide bindingSignaling pathways348 ~ 435313 ~ 439339 ~ 446262 ~ 461340 ~ 558250 ~ 465Mouse Cardiac cell/ Mouse embryoGPC1Glypican-1 (NM_016696)Fibroblast growth factor binding365 ~ 582Mouse embryoITSN1Intersectin 1 (NM_010587)Guanyl-nucleotide exchange factor activity; Rho guanyl-nucleotide exchange factor activity; calcium ion binding3410 ~ 526Mouse embryoPPP3CBProtein phosphatase 3, catalytic subunit, beta isoform (NM_008914)Calmodulin-dependent protein phosphatase activity3249 ~ 554Mouse B cellFCHSD2FCHSD2/Carom/FCH and double SH3 domains 2/F-BAR And Double SH3 Domains Protein 2 (NM_001146010)Phosphatidylinositol-3,4,5-trisphosphate binding3367 ~ 523Mouse Cardiac cellSTAM1Signal-Transducing Adaptor Molecule 1 (NM_011484)Ubiquitin-like protein ligase binding3242 ~ 419251 ~ 419269 ~ 419Mouse B cell/Mouse embryoALS2CR2STE20-related kinase adapter protein beta; STRADB (NM_172656)Protein serine/threonine kinase activity; ATP binding34 ~ 209Mouse Cardiac cellTNIP3TNFAIP3 Interacting Protein 1, A20-binding inhibitor of NF-κB activation (ABIN-1) (NM_001001495)Protein deubiquitination; identical protein binding; MAPK binding3259 ~ 554Mouse B cellTNIP1TNFAIP3 Interacting Protein 3), A20-binding inhibitor of NF-κB activation (ABIN-3) (NM_021327)Protein deubiquitination; identical protein binding; MAPK bindingProtein processing/translocation3− 37 ~ 50Mouse embryoAHSA1AHA1, Activator of Heat Shock 90 kDa Protein ATPase Homolog 1 (NM_146036)ATPase activator activity; Hsp90 protein binding; extracellular exosome33 ~ 27952 ~ 279− 5 ~ 27914 ~ 279Mouse B cell/Cardiac cell/Mouse embryoC1QBPComplement component 1 Q subcomponent-binding protein, mitochondrial (NM_007573)Mitochondrial ribosome binding; mRNA binding; translation activator activityOthers3269 ~ 376302 ~ 383Mouse embryoKLHDC3Kelch domain containing 3,transcript 1 (NM_027910)Chromatin binding; meiotic recombination
Source: 56 zebrafish Udu and mouse GON4L interacting candidates are identified by yeast 2-hybrid analyses. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Laboratory / cell research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
HEK293 or COS-7 cells were cultured in Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin (Invitrogen).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Newly identified Gon4l/Udu-interacting proteins implicate novel functions
Study design awaiting verification · Scientific Reports · 2020
Original publication title
Newly identified Gon4l/Udu-interacting proteins implicate novel functions
© The Author(s) 2020
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Mutations of the Gon4l/udu gene in different organisms give rise to diverse phenotypes. Although the effects of Gon4l/Udu in transcriptional regulation have been demonstrated, they cannot solely explain the observed characteristics among species. To further understand the function of Gon4l/Udu, we used yeast two-hybrid (Y2H) screening to identify interacting proteins in zebrafish and mouse systems, confirmed the interactions by co-immunoprecipitation assay, and found four novel Gon4l-interacting proteins: BRCA1 associated protein-1 (Bap1), DNA methyltransferase 1 (Dnmt1), Tho complex 1 (Thoc1, also known as Tho1 or HPR1), and Cryptochrome circadian regulator 3a (Cry3a).
Furthermore, all known Gon4l/Udu-interacting proteins: as found in this study, in previous reports, and in online resources: were investigated by Phenotype Enrichment Analysis. The most enriched phenotypes identified include increased embryonic tissue cell apoptosis, embryonic lethality, increased T cell derived lymphoma incidence, decreased cell proliferation, chromosome instability, and abnormal dopamine level, characteristics that largely resemble those observed in reported Gon4l/udu mutant animals. Similar to the expression pattern of udu, those of bap1, dnmt1, thoc1, and cry3a are also found in the brain region and other tissues.
Thus, these findings indicate novel mechanisms of Gon4l/Udu in regulating CpG methylation, histone expression/modification, DNA repair/genomic stability, and RNA binding/processing/export.
Authors’ abstract
Mutations of the Gon4l/udu gene in different organisms give rise to diverse phenotypes. Although the effects of Gon4l/Udu in transcriptional regulation have been demonstrated, they cannot solely explain the observed characteristics among species. To further understand the function of Gon4l/Udu, we used yeast two-hybrid (Y2H) screening to identify interacting proteins in zebrafish and mouse systems, confirmed the interactions by co-immunoprecipitation assay, and found four novel Gon4l-interacting proteins: BRCA1 associated protein-1 (Bap1), DNA methyltransferase 1 (Dnmt1), Tho complex 1 (Thoc1, also known as Tho1 or HPR1), and Cryptochrome circadian regulator 3a (Cry3a).
Furthermore, all known Gon4l/Udu-interacting proteins: as found in this study, in previous reports, and in online resources: were investigated by Phenotype Enrichment Analysis. The most enriched phenotypes identified include increased embryonic tissue cell apoptosis, embryonic lethality, increased T cell derived lymphoma incidence, decreased cell proliferation, chromosome instability, and abnormal dopamine level, characteristics that largely resemble those observed in reported Gon4l/udu mutant animals. Similar to the expression pattern of udu, those of bap1, dnmt1, thoc1, and cry3a are also found in the brain region and other tissues.
Thus, these findings indicate novel mechanisms of Gon4l/Udu in regulating CpG methylation, histone expression/modification, DNA repair/genomic stability, and RNA binding/processing/export.
Publication and source details
Original title: Newly identified Gon4l/Udu-interacting proteins implicate novel functions
Su-Mei Tsai; Kuo-Chang Chu; Yun-Jin Jiang
Scientific Reports · 2020
© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.National Health Research InstitutesMG-102-PP-13MG-103-PP-13MG-109-PP-9Jiang Yun-JinRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T14:39:00.776072+00:00
DOI: 10.1038/s41598-020-70855-9 · PMC7449961